X0306 4 2013-03-12 0 0001367644 Emergent BioSolutions Inc. EBS 0001380956 Kramer Robert 2273 RESEARCH BLVD SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Financial Officer Common Stock 2013-03-12 4 A 0 3940 0 A 29311 D Common Stock 856043 I By BioPharm, L.L.C. Employee Stock Option (right to buy) 14.67 2013-03-12 4 A 0 7879 0 A 2020-03-11 Common Stock 7879 7879 D Mr. Kramer's direct holdings include restricted stock units granted under the Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan and shares distributed from BioPharm, L.L.C. to Mr. Kramer through RKRAMER L.L.C. These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Vests in three equal installments on March 11, 2014, March 11, 2015 and March 11, 2016. Mr. Kramer is the general manager of RKRAMER, L.L.C., which holds 21.01% of the equity interest in BioPharm, L.L.C. BioPharm, L.L.C. is the direct owner of 856,043 shares of Common Stock. Mr. Kramer disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuniary interest in 181,746 units in BioPharm L.L.C. held directly through RKRAMER L.L.C. /s/Jay G. Reilly, attorney-in-fact 2013-03-12